NFAT activation by FKBP52 promotes cancer cell proliferation by suppressing p53
Life Science Alliance · 2024
DOI: 10.26508/lsa.202302426 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, 2024. Verfasst von Shunsuke Hanaki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Biochemistry, Yamaguchi University, Yamaguchi, Japan. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Tacrolimus Binding Proteins, Cell Proliferation, NFATC Transcription Factors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Canon Medical Systems Corporation, MEXT | JST | Fusion Oriented REsearch for disruptive Science and Technology.
Abstract (Originalsprache)
FK506-binding protein 52 (FKBP52) is a member of the FKBP family of proline isomerases. FKBP52 is up-regulated in various cancers and functions as a positive regulator of steroid hormone receptors. Depletion of FKBP52 is known to inhibit cell proliferation; however, the detailed mechanism remains poorly understood. In this study, we found that FKBP52 depletion decreased MDM2 transcription, leading to stabilization of p53, and suppressed cell proliferation. We identified NFATc1 and NFATc3 as transcription factors that regulate MDM2 . We also found that FKBP52 associated with NFATc3 and facilitated its nuclear translocation. In addition, calcineurin, a well-known Ca 2+ phosphatase essential for activation of NFAT, plays a role in MDM2 transcription. Supporting this notion, MDM2 expression was found to be regulated by intracellular Ca 2+ . Taken together, these findings reveal a new role of FKBP52 in promoting cell proliferation via the NFAT-MDM2-p53 axis, and indicate that inhibition of FKBP52 could be a new therapeutic tool to activate p53 and inhibit cell proliferation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Veterinary Biochemistry, Yamaguchi University, Yamaguchi, Japan.
- Department of Veterinary Hygiene, Yamaguchi University, Yamaguchi, Japan.
- Department of Veterinary Biochemistry, Yamaguchi University, Yamaguchi, Japan shimada@med.nagoya-u.ac.jp.
- Department of Molecular Biology, Nagoya University, Graduate School of Medicine, Nagoya, Japan.
ORCID-Profile: Makoto Habara, Midori Shimada
Förderung
- Japan Society for the Promotion of Science
- Canon Medical Systems Corporation
- MEXT | JST | Fusion Oriented REsearch for disruptive Science and Technology
Zitieren
APA
Hanaki, S., Habara, M., Tomiyasu, H., Sato, Y., Miki, Y., Masaki, T., Shibutani, S., & Shimada, M. (2024). NFAT activation by FKBP52 promotes cancer cell proliferation by suppressing p53. Life Science Alliance. https://doi.org/10.26508/lsa.202302426
Vancouver
Hanaki S, Habara M, Tomiyasu H, Sato Y, Miki Y, Masaki T, et al. NFAT activation by FKBP52 promotes cancer cell proliferation by suppressing p53. Life Science Alliance. 2024. doi:10.26508/lsa.202302426
BibTeX
@article{Hanaki2024,
author = {Hanaki, Shunsuke and Habara, Makoto and Tomiyasu, Haruki and Sato, Yuki and Miki, Yosei and Masaki, Takahiro and Shibutani, Shusaku and Shimada, Midori},
title = {NFAT activation by FKBP52 promotes cancer cell proliferation by suppressing p53},
journal = {Life Science Alliance},
year = {2024},
doi = {10.26508/lsa.202302426}
}
EUVIMED